Published 2022
| Version v1
Publication
In-vivo treatment with the GPR17 antagonist montelukast ameliorated the lifespan and delayed the disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Additional details
Identifiers
- URL
- https://hdl.handle.net/11567/1156575
- URN
- urn:oai:iris.unige.it:11567/1156575
Origin repository
- Origin repository
- UNIGE